| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |